The FDA says shortages of GLP-1s are over, but many patients are still getting what are essentially copied medications.

Experts reveal potential unintended Ozempic side effect – and whether we should worry - Researchers found Ozempic-induced weight loss decreased muscle mass by about 10 per cent ...

Novo Nordisk, the Danish drugmaker behind the popular obesity drug Wegovy, warns of fierce competition and market pressures, potentially leading to layoffs. As compounders produce cheaper copycats, U.

Novo Nordisk stock slumped Wednesday after saying it expects compounded versions to undercut sales of its obesity drug, ...